BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9513208)

  • 1. [Autoantibody to glutamate decarboxylase in a patient with spinocerebellar degeneration and Sjögren syndrome].
    Ikeda J; Harada T; Kamei H; Nakamura S
    No To Shinkei; 1998 Feb; 50(2):177-80. PubMed ID: 9513208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of an old woman with Sjögren's syndrome associated with insulin-dependent diabetes mellitus].
    Takeuchi K; Hori Y; Hayakawa T; Hashimoto H; Atsumi T; Hirose K; Sakai K; Nishikawa T; Miwa A; Takashiro Y; Suzuki T
    Ryumachi; 1996 Oct; 36(5):769-74. PubMed ID: 8969557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
    Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
    Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
    Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological reactivity against neuronal and non-neuronal antigens in sporadic adult-onset cerebellar ataxia.
    Fancellu R; Pareyson D; Corsini E; Salsano E; Laurà M; Bernardi G; Antozzi C; Andreetta F; Colecchia M; Di Donato S; Mariotti C
    Eur Neurol; 2009; 62(6):356-61. PubMed ID: 19786780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies against a 72-kDa ductal cell membrane glycoprotein in a patient affected by Sjögren's syndrome and gastric MALT lymphoma.
    Folli F; Perego L; Ponzoni M; Girardi AM; Bosi E; Ferreri AJ; Bellone M; Sabbadini MG; Vicari AM; Trusolino L
    Ann Hematol; 2002 Oct; 81(10):597-602. PubMed ID: 12424543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome.
    Dinkel K; Meinck HM; Jury KM; Karges W; Richter W
    Ann Neurol; 1998 Aug; 44(2):194-201. PubMed ID: 9708541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of myasthenia gravis accompanied by large thymoma and anti-GAD antibody].
    Kitae S; Kawakami H; Matsuoka N; Etoh R; Nakamura S
    Rinsho Shinkeigaku; 2001 Nov; 41(11):818-21. PubMed ID: 12080617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of paraneoplastic cerebellar degeneration--success in early detection of cancer by anti-Purkinje cell antibody].
    Igarashi S; Tanaka K; Nakajima T; Yamazaki M; Inuzuka T; Miyatake T
    Rinsho Shinkeigaku; 1992 Mar; 32(3):309-13. PubMed ID: 1628454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Subacute neuropathy, multiple cancers, and Gougerot-Sjögren syndrome: contribution of anti-Hu antibody].
    Auf G; Benyahia B; Orcel B; Beigelman C; Delattre JY
    Rev Neurol (Paris); 2001 Feb; 157(2):219-21. PubMed ID: 11283468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebellar degeneration in primary Sjögren syndrome: a case report.
    Chuah SL; Jobli AT; Wan SA; Teh CL
    J Med Case Rep; 2021 Oct; 15(1):526. PubMed ID: 34663471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebellar degeneration in primary Sjӧgren syndrome.
    Heidary M; Alesaeidi S; Afshari K
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29880622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase.
    Ishida K; Mitoma H; Song SY; Uchihara T; Inaba A; Eguchi S; Kobayashi T; Mizusawa H
    Ann Neurol; 1999 Aug; 46(2):263-7. PubMed ID: 10443895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase.
    Markakis I; Alexiou E; Xifaras M; Gekas G; Rombos A
    Clin Neurol Neurosurg; 2008 Jun; 110(6):619-21. PubMed ID: 18433986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralization of muscarinic receptor autoantibodies by intravenous immunoglobulin in Sjögren syndrome.
    Smith AJ; Jackson MW; Wang F; Cavill D; Rischmueller M; Gordon TP
    Hum Immunol; 2005 Apr; 66(4):411-6. PubMed ID: 15866705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor weakness and cerebellar ataxia in Sjögren syndrome--identification of antineuronal antibody: a case report.
    Owada K; Uchihara T; Ishida K; Mizusawa H; Watabiki S; Tsuchiya K
    J Neurol Sci; 2002 May; 197(1-2):79-84. PubMed ID: 11997071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-Titre GAD Antibody-Associated Late-Onset Cerebellar Ataxia with a Significant Clinical Response to Intravenous Immunoglobulin Treatment.
    Petrijan T; Menih M
    Cerebellum; 2017 Aug; 16(4):868-871. PubMed ID: 28321713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of primary Sjögren's syndrome presenting with aseptic meningoencephalitis associated with sarcoidosis].
    Nishida H; Tanaka Y; Yasuda S; Yamada M
    No To Shinkei; 1999 Apr; 51(4):349-52. PubMed ID: 10363271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamic acid decarboxylase autoantibodies and neurological disorders.
    Vianello M; Tavolato B; Giometto B
    Neurol Sci; 2002 Oct; 23(4):145-51. PubMed ID: 12536283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ataxic sensory and autonomic neuropathies associated with primary Sjögren's syndrome: a case report].
    Oobayashi Y; Miyawaki S
    Ryumachi; 1995 Feb; 35(1):107-11. PubMed ID: 7732483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.